Cargando…
ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies
The rapid spread of severe acute respiratory syndrome coronavirus 2 infection and its related disease (COVID-19) has required an immediate and coordinate healthcare response to face the worldwide emergency and define strategies to maintain the continuum of care for the non-COVID-19 diseases while pr...
Autores principales: | Colombo, Ilaria, Zaccarelli, Eleonora, Del Grande, Maria, Tomao, Federica, Multinu, Francesco, Betella, Ilaria, Ledermann, Jonathan A, Gonzalez-Martin, Antonio, Sessa, Cristiana, Colombo, Nicoletta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388889/ https://www.ncbi.nlm.nih.gov/pubmed/32718919 http://dx.doi.org/10.1136/esmoopen-2020-000827 |
Ejemplares similares
-
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up
por: Colombo, Nicoletta, et al.
Publicado: (2016) -
Advancing antibody-drug conjugates in gynecological malignancies: myth or reality?
por: Nerone, Marta, et al.
Publicado: (2022) -
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy
por: Fumagalli, Caterina, et al.
Publicado: (2019) -
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
por: Passaro, Antonio, et al.
Publicado: (2020) -
ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer
por: Catanese, Silvia, et al.
Publicado: (2020)